NCT01167049 Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis Status UNKNOWN Phase PHASE2
NCT01158274 RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT01152710 Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer Status COMPLETED Phase PHASE2
NCT01151761 Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation Status TERMINATED Phase PHASE2
NCT01150630 Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01134601 A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum Status TERMINATED Phase PHASE1
NCT01132664 Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01131078 A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status COMPLETED Phase PHASE2
NCT01128842 A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor Status COMPLETED Phase PHASE1
NCT01123473 Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer Status TERMINATED Phase PHASE2
NCT01118377 A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas Status COMPLETED Phase PHASE2
NCT01112826 Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer Status COMPLETED Phase PHASE3
NCT01099527 A Trial of RAD001/Capecitabine in Refractory Gastric Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01097265 Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT01097018 Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer Status COMPLETED Phase PHASE3
NCT01095003 Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01079702 Everolimus and Capecitabine in Patients With Advanced Malignancy Status UNKNOWN Phase PHASE1/PHASE2
NCT01077986 Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2